News In Brief
This article was originally published in The Gray Sheet
Executive Summary
FDA device funding flat in Senate bill
You may also be interested in...
Blues TEC Assessment Endorses CRT For Mild Heart Failure
Using cardiac resynchronization therapy to treat patients suffering from mild heart failure is supported by existing clinical evidence. That is not the case, however, for asymptomatic patients, according to a new assessment issued by Blue Cross Blue Shield’s Technology Evaluation Center.
News In Brief
Qiagen proposes Ipsogen purchase
Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Gel
Theradaptive, which makes a device-biologic combination product to help speed bone healing, recently got authorization to start human trials from the US FDA. Medtech Insight spoke to CEO Luis Alvarez about the company’s past, present and future.